Levetiracetam Brill Pharma

Levetiracetam, the active ingredient in Levetiracetam Brill Pharma, is an anticonvulsant presented as an oral tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Brill Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to manage epileptic seizures by modulating neuronal excitability.

Partial seizures: reduces the frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps control convulsive episodes. Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Blood dyscrasias such as neutropenia - Severe skin rash - Multi‑organ hypersensitivity reactions

Before initiating therapy, clinicians should consider several safety factors.

Renal impairment: adjust dose based on creatinine clearance. Hepatic dysfunction: monitor liver function tests. Pregnancy: risk category unknown; discuss benefits and risks with a physician. Psychiatric symptoms: monitor for mood changes or aggression. Concomitant CNS depressants: use caution due to additive sedation. Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenytoin: may reduce levetiracetam exposure. - Phenobarbital: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels. - Topiramate: additive central nervous system depression. - Alcohol: enhanced sedation and dizziness.